Abstract
We evaluated paroxetine for the treatment of fatigue and depression in patients with solid tumors after chemotherapy, and we found that paroxetine is effective for the treatment of depression during chemotherapy but has no benefit for the treatment of fatigue.
Publication types
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antidepressive Agents, Second-Generation / therapeutic use*
-
Antineoplastic Agents / adverse effects*
-
Depression / chemically induced
-
Depression / complications
-
Depression / diagnosis
-
Depression / drug therapy*
-
Double-Blind Method
-
Drug Administration Schedule
-
Fatigue / chemically induced
-
Fatigue / complications
-
Fatigue / diagnosis
-
Fatigue / drug therapy*
-
Female
-
Humans
-
Male
-
Middle Aged
-
Paroxetine / therapeutic use*
-
Prospective Studies
-
Surveys and Questionnaires
-
Treatment Outcome
Substances
-
Antidepressive Agents, Second-Generation
-
Antineoplastic Agents
-
Paroxetine